BE study design issue [Design Issues]

posted by jag009  – NJ, 2019-12-14 00:26 (1581 d 12:37 ago) – Posting: # 20973
Views: 4,133

Hi everyone,

Question, if one conducted a study comparing ER to an immediate release reference but not following the recommended dosage regimen of the IR. Example, as per product monograph IR is given every 4 hrs and the new ER is given every 8 hrs, but the guy designed the pk study comparing ER vs 2xIR with both give at time 0, The design is obviously wrong (due to IR dosing regimen) but would a regulatory body reject the study (assume the study pass the BE objective which is BE needed only for auc). A pivotal study not pilot.

PS, not me! Doing some due diligence..
Thx
J

Complete thread:

UA Flag
Activity
 Admin contact
22,980 posts in 4,821 threads, 1,659 registered users;
25 visitors (0 registered, 25 guests [including 12 identified bots]).
Forum time: 14:03 CEST (Europe/Vienna)

Never, never, never use any software!
Never, never, never trust any computer!    Detlew Labes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5